NJ S3394 | 2022-2023 | Regular Session
Note: Carry Foward to future A913
Note: Carry Foward to future S2392
Note: Carry Foward to future S2392
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on December 15 2022 - 25% progression, died in committee
Action: 2022-12-15 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Pending: Senate Health, Human Services and Senior Citizens Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on December 15 2022 - 25% progression, died in committee
Action: 2022-12-15 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Pending: Senate Health, Human Services and Senior Citizens Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Authorizes medical cannabis for treatment of sickle cell anemia.
Title
Authorizes medical cannabis for treatment of sickle cell anemia.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2022-12-15 | Senate | Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee |
Same As/Similar To
S3394 (Carry Over) 2022-12-15 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
S3394 (Carry Over) 2022-12-15 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
A4944 (Same As) 2022-12-08 - Introduced, Referred to Assembly Health Committee
S3394 (Carry Over) 2022-12-15 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
A4944 (Same As) 2022-12-08 - Introduced, Referred to Assembly Health Committee
Subjects
New Jersey State Sources
Type | Source |
---|---|
Summary | https://www.njleg.state.nj.us/bill-search/2022/S3394 |
Text | https://pub.njleg.gov/Bills/2022/S3500/3394_I1.HTM |